Bhattacharjee Sarah, Pirkle Sean, Shi Lewis L, Lee Michael J
Pritzker School of Medicine, The University of Chicago, 924 E. 57th St., Suite 104, Chicago, IL, 60637, USA.
Department of Orthopaedic Surgery and Rehabilitation Medicine, The University of Chicago, Chicago, IL, USA.
Eur Spine J. 2020 Jul;29(7):1686-1692. doi: 10.1007/s00586-020-06410-x. Epub 2020 Apr 18.
Lumbar epidural steroid injections (LESIs) are widely utilized for back pain. However, as studies report adverse effects from these injections, defining a safe interval for their use preoperatively is necessary. We investigated the effects of preoperative LESI timing on the rates of recurrent microdiscectomy.
This study utilized the PearlDiver national insurance claims database. Microdiscectomy patients were stratified by the timing of their most recent LESI prior to surgery into bimonthly cohorts (0-2 months, 2-4 months, 4-6 months). This first cohort was further stratified into biweekly cohorts (0-2 weeks, 2-4 weeks, 4-6 weeks, 6-8 weeks). The 6-month reoperation rate was assessed and compared between each injection cohort and a control group of patients with no injections within 6 months before surgery. Univariate analyses of reoperation were conducted followed by multivariate analyses controlling for risk factors where appropriate.
A total of 12,786 microdiscectomy patients were identified; 1090 (8.52%) received injections within 6 months before surgery. We observed a significant increase in the 6-month reoperation rates in patients who received injections within 6 weeks prior to surgery (odds ratio [OR] 1.900, 1.218-2.963; p = 0.005) compared to control. No other significant differences were observed.
In this study, microdiscectomy performed within 6 weeks following LESIs was associated with a higher risk of reoperation, while microdiscectomy performed more than 6 weeks from the most recent LESI demonstrated no such association with increased risk. Further research into the interaction between LESIs and recurrent disk herniation is necessary.
腰椎硬膜外类固醇注射(LESI)被广泛用于治疗背痛。然而,由于研究报告了这些注射的不良反应,因此术前确定其安全使用间隔是必要的。我们研究了术前LESI时间对复发性显微椎间盘切除术发生率的影响。
本研究使用了PearlDiver国家保险索赔数据库。显微椎间盘切除术患者根据术前最近一次LESI的时间分层为每两个月一组(0 - 2个月、2 - 4个月、4 - 6个月)。第一组进一步分层为每两周一组(0 - 2周、2 - 4周、4 - 6周、6 - 8周)。评估并比较每个注射组与术前6个月内未注射的对照组患者的6个月再次手术率。进行再次手术的单因素分析,然后在适当情况下对危险因素进行多因素分析。
共确定了12786例显微椎间盘切除术患者;1090例(8.52%)在术前6个月内接受了注射。我们观察到,与对照组相比,术前6周内接受注射的患者6个月再次手术率显著增加(优势比[OR]1.900,1.218 - 2.963;p = 0.005)。未观察到其他显著差异。
在本研究中,LESI后6周内进行的显微椎间盘切除术与再次手术风险较高相关,而距最近一次LESI超过6周进行的显微椎间盘切除术未显示出这种风险增加的关联。有必要进一步研究LESI与复发性椎间盘突出之间的相互作用。